{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:48Z","timestamp":1793157948914,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA260476"],"award-info":[{"award-number":["CA260476"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012802","name":"Ragon Institute of MGH, MIT and Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Al158571"],"award-info":[{"award-number":["Al158571"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID-19 pandemic marks the third coronavirus pandemic this century (SARS-CoV-1, MERS, SARS-CoV-2), emphasizing the need to identify and evaluate conserved immunogens for a pan-sarbecovirus vaccine. Here we investigate the potential utility of a T-cell vaccine strategy targeting conserved regions of the sarbecovirus proteome. We identified the most conserved regions of the sarbecovirus proteome as portions of the RNA-dependent RNA polymerase (RdRp) and Helicase proteins, both of which are part of the coronavirus replication transcription complex (RTC). Fitness constraints suggest that as SARS-CoV-2 continues to evolve these regions may better preserve cross-reactive potential of T-cell responses than Spike, Nucleocapsid, or Membrane proteins. We sought to determine if vaccine-elicited T-cell responses to the highly conserved regions of the RTC would reduce viral loads following challenge with SARS-CoV-2 in mice using a rhesus adenovirus serotype 52 (RhAd52) vector. The RhAd52.CoV.Consv vaccine generated robust cellular immunity in mice and led to significant reductions in viral loads in the nasal turbinates following challenge with a mouse-adapted SARS-CoV-2. These data suggest the potential utility of T-cell targeting of conserved regions for a pan-sarbecovirus vaccine.<\/jats:p>","DOI":"10.1038\/s41541-022-00553-2","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T15:22:48Z","timestamp":1666884168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-6074","authenticated-orcid":false,"given":"Gabriel","family":"Dagotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-3242","authenticated-orcid":false,"given":"John D.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tochi","family":"Anioke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-5152","authenticated-orcid":false,"given":"Mazuba","family":"Siamatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5857-3632","authenticated-orcid":false,"given":"Julia","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-4923","authenticated-orcid":false,"given":"Alexandra","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-5684","authenticated-orcid":false,"given":"Lisa H.","family":"Tostanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-8701","authenticated-orcid":false,"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-5757","authenticated-orcid":false,"given":"Bette","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5127-4659","authenticated-orcid":false,"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"553_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"553_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus\u2014infected pneumonia. N. Engl. J. Med. 382, 1199\u20131207 (2020).","journal-title":"N. Engl. J. Med."},{"key":"553_CR3","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMc2100362","volume":"384","author":"SS Abdool Karim","year":"2021","unstructured":"Abdool Karim, S. S. & de Oliveira, T. New SARS-CoV-2 variants\u2014clinical, public health, and vaccine implications. N. Engl. J. Med. 384, 1866\u20131868 (2021).","journal-title":"N. Engl. J. Med."},{"key":"553_CR4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek, T. G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953\u20131966 (2003).","journal-title":"N. Engl. J. Med."},{"key":"553_CR5","first-page":"e00884","volume":"5","author":"AN Alagaili","year":"2014","unstructured":"Alagaili, A. N. et al. Middle east respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. mBio 5, e00884\u201300814 (2014).","journal-title":"mBio"},{"key":"553_CR6","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"M Romano","year":"2020","unstructured":"Romano, M., Ruggiero, A., Squeglia, F., Maga, G. & Berisio, R. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells 9, 1267 (2020).","journal-title":"Cells"},{"key":"553_CR7","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.cell.2020.07.033","volume":"182","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex. Cell 182, 1560\u20131573.e1513 (2020).","journal-title":"Cell"},{"key":"553_CR8","doi-asserted-by":"publisher","unstructured":"Swadling, L. et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature, https:\/\/doi.org\/10.1038\/s41586-021-04186-8 (2021).","DOI":"10.1038\/s41586-021-04186-8"},{"key":"553_CR9","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2666-5247(21)00146-4","volume":"2","author":"RK Gupta","year":"2021","unstructured":"Gupta, R. K. et al. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study. Lancet Microbe 2, e508\u2013e517 (2021).","journal-title":"Lancet Microbe"},{"key":"553_CR10","doi-asserted-by":"publisher","first-page":"eabg5669","DOI":"10.1126\/sciimmunol.abg5669","volume":"6","author":"V Mallajosyula","year":"2021","unstructured":"Mallajosyula, V. et al. CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19. Sci. Immunol. 6, eabg5669 (2021).","journal-title":"Sci. Immunol."},{"key":"553_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis, N. & Ertl, H. C. J. Adenoviruses as vaccine vectors. Mol. Ther. 10, 616\u2013629 (2004).","journal-title":"Mol. Ther."},{"key":"553_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/hum.2005.16.149","volume":"16","author":"DH Barouch","year":"2005","unstructured":"Barouch, D. H. & Nabel, G. J. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum. gene Ther. 16, 149\u2013156 (2005).","journal-title":"Hum. gene Ther."},{"key":"553_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","volume":"586","author":"KH Dinnon","year":"2020","unstructured":"Dinnon, K. H. et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560\u2013566 (2020).","journal-title":"Nature"},{"key":"553_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","volume":"183","author":"SR Leist","year":"2020","unstructured":"Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070\u20131085.e1012 (2020).","journal-title":"Cell"},{"key":"553_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nm1461","volume":"13","author":"W Fischer","year":"2007","unstructured":"Fischer, W. et al. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat. Med. 13, 100\u2013106 (2007).","journal-title":"Nat. Med."},{"key":"553_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep33987","volume":"6","author":"J Theiler","year":"2016","unstructured":"Theiler, J. et al. Epigraph: a vaccine design tool applied to an HIV therapeutic vaccine and a Pan-Filovirus vaccine. Sci. Rep. 6, 33987 (2016).","journal-title":"Sci. Rep."},{"key":"553_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","volume":"368","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368, 779\u2013782 (2020).","journal-title":"Science"},{"key":"553_CR18","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/jmv.27516","volume":"94","author":"L Wang","year":"2022","unstructured":"Wang, L. & Cheng, G. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa. J. Med. Virol. 94, 1728\u20131733 (2022).","journal-title":"J. Med. Virol."},{"key":"553_CR19","doi-asserted-by":"publisher","first-page":"e00849","DOI":"10.1128\/MRA.00849-21","volume":"10","author":"TA Banu","year":"2021","unstructured":"Banu, T. A. et al. Genome sequencing of the SARS-CoV-2 Delta (B.1.617.2) variant of concern detected in Bangladesh. Microbiol. Resour. Announcements 10, e00849\u201300821 (2021).","journal-title":"Microbiol. Resour. Announcements"},{"key":"553_CR20","doi-asserted-by":"publisher","unstructured":"Liu, J. et al. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 omicron. Nature https:\/\/doi.org\/10.1038\/s41586-022-04465-y (2022).","DOI":"10.1038\/s41586-022-04465-y"},{"key":"553_CR21","doi-asserted-by":"publisher","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 spike cross-recognize omicron. Nature https:\/\/doi.org\/10.1038\/s41586-022-04460-3 (2022).","DOI":"10.1038\/s41586-022-04460-3"},{"key":"553_CR22","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.xcrm.2021.100204","volume":"2","author":"A Tarke","year":"2021","unstructured":"Tarke, A. et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep. Med. 2, 100204 (2021).","journal-title":"Cell Rep. Med."},{"key":"553_CR23","doi-asserted-by":"publisher","first-page":"e00404","DOI":"10.1128\/JVI.00404-21","volume":"95","author":"SJ Vidal","year":"2021","unstructured":"Vidal, S. J. et al. Correlates of neutralization against SARS-CoV-2 variants of concern by early pandemic sera. J. Virol. 95, e00404\u2013e00421 (2021).","journal-title":"J. Virol."},{"key":"553_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui, J., Li, F. & Shi, Z. L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181\u2013192 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"553_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/22221751.2022.2040341","volume":"11","author":"AN Vlasova","year":"2022","unstructured":"Vlasova, A. N. et al. Animal alphacoronaviruses found in human patients with acute respiratory illness in different countries. Emerg. Microbes Infect. 11, 699\u2013702 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"553_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.372.6545.893","volume":"372","author":"A King","year":"2021","unstructured":"King, A. Two more coronaviruses may infect people. Science 372, 893\u2013893 (2021).","journal-title":"Science"},{"key":"553_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00454-4","volume":"7","author":"SH Mahrokhian","year":"2022","unstructured":"Mahrokhian, S. H. et al. Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice. npj Vaccines 7, 23 (2022).","journal-title":"npj Vaccines"},{"key":"553_CR28","doi-asserted-by":"publisher","first-page":"e00974","DOI":"10.1128\/JVI.00974-21","volume":"95","author":"LH Tostanoski","year":"2021","unstructured":"Tostanoski, L. H. et al. Protective efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2. J. Virol. 95, e00974\u201300921 (2021).","journal-title":"J. Virol."},{"key":"553_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","volume":"590","author":"K McMahan","year":"2021","unstructured":"McMahan, K. et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature 590, 630\u2013634 (2021).","journal-title":"Nature"},{"key":"553_CR30","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s41591-020-1070-6","volume":"26","author":"LH Tostanoski","year":"2020","unstructured":"Tostanoski, L. H. et al. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat. Med. 26, 1694\u20131700 (2020).","journal-title":"Nat. Med."},{"key":"553_CR31","doi-asserted-by":"publisher","first-page":"eabb9153","DOI":"10.1126\/sciadv.abb9153","volume":"6","author":"X Li","year":"2020","unstructured":"Li, X. et al. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Sci. Adv. 6, eabb9153 (2020).","journal-title":"Sci. Adv."},{"key":"553_CR32","unstructured":"Reza, F. M. An introduction to information theory. 76-124 (Courier Corporation, 1994)."},{"key":"553_CR33","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1128\/jvi.68.11.7467-7481.1994","volume":"68","author":"BT Korber","year":"1994","unstructured":"Korber, B. T. et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68, 7467\u20137481 (1994).","journal-title":"J. Virol."},{"key":"553_CR34","doi-asserted-by":"crossref","unstructured":"Alkhovsky, S. et al. SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020. Viruses 14, 113 (2022).","DOI":"10.3390\/v14010113"},{"key":"553_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26809-4","volume":"12","author":"D Delaune","year":"2021","unstructured":"Delaune, D. et al. A novel SARS-CoV-2 related coronavirus in bats from Cambodia. Nat. Commun. 12, 6563 (2021).","journal-title":"Nat. Commun."},{"key":"553_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nature12711","volume":"503","author":"X-Y Ge","year":"2013","unstructured":"Ge, X.-Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535\u2013538 (2013).","journal-title":"Nature"},{"key":"553_CR37","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1073\/pnas.0409608102","volume":"102","author":"H-D Song","year":"2005","unstructured":"Song, H.-D. et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl Acad. Sci. 102, 2430\u20132435 (2005).","journal-title":"Proc. Natl Acad. Sci."},{"key":"553_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41586-022-04532-4","volume":"604","author":"S Temmam","year":"2022","unstructured":"Temmam, S. et al. Bat coronaviruses related to SARS-CoV-2 and infectious for human cells. Nature 604, 330\u2013336 (2022).","journal-title":"Nature"},{"key":"553_CR39","doi-asserted-by":"publisher","unstructured":"Wells, H. L. et al. The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus. Virus Evol. 7, https:\/\/doi.org\/10.1093\/ve\/veab007 (2021).","DOI":"10.1093\/ve\/veab007"},{"key":"553_CR40","doi-asserted-by":"publisher","unstructured":"Wu, Z. et al. A comprehensive survey of bat sarbecoviruses across China in relation to the origins of SARS-CoV and SARS-CoV-2. Natl Sci. Rev. https:\/\/doi.org\/10.1093\/nsr\/nwac213 (2022).","DOI":"10.1093\/nsr\/nwac213"},{"key":"553_CR41","doi-asserted-by":"publisher","first-page":"W232","DOI":"10.1093\/nar\/gkw256","volume":"44","author":"J Trifinopoulos","year":"2016","unstructured":"Trifinopoulos, J., Nguyen, L.-T., von Haeseler, A. & Minh, B. Q. W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis. Nucleic Acids Res. 44, W232\u2013W235 (2016).","journal-title":"Nucleic Acids Res."},{"key":"553_CR42","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/JVI.02696-06","volume":"81","author":"P Abbink","year":"2007","unstructured":"Abbink, P. et al. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81, 4654\u20134663 (2007).","journal-title":"J. Virol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00553-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00553-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00553-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T15:30:34Z","timestamp":1666884634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00553-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1038\/s41541-022-00553-2","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"28 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}